AAAAAA

   
Results: 1-25 | 26-31 |
Results: 26-31/31

Authors: Oehler, MK Bicknell, R
Citation: Mk. Oehler et R. Bicknell, The promise of anti-angiogenic cancer therapy, BR J CANC, 82(4), 2000, pp. 749-752

Authors: Crew, JP Fuggle, S Bicknell, R Cranston, DW de Benedetti, A Harris, AL
Citation: Jp. Crew et al., Eukaryotic initiation factor-4E in superficial and muscle invasive bladdercancer and its correlation with vascular endothelial growth factor expression and tumour progression, BR J CANC, 82(1), 2000, pp. 161-166

Authors: Lau, KKW Bicknell, R
Citation: Kkw. Lau et R. Bicknell, Antiangiogenic gene therapy, GENE THER, 6(11), 1999, pp. 1793-1795

Authors: Sivridis, E Giatromanolaki, A Koukourakis, MI Bicknell, R Harris, AL Gatter, KC
Citation: E. Sivridis et al., Thymidine phosphorylase expression in endometrial carcinomas, CLIN EXP M, 17(5), 1999, pp. 445-450

Authors: Crew, JP O'Brien, T Bicknell, R Fuggle, S Cranston, D Harris, AL
Citation: Jp. Crew et al., Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates, J UROL, 161(3), 1999, pp. 799-804

Authors: Crew, JP O'Brien, T Bicknell, R Fuggle, S Cranston, D Harris, AL
Citation: Jp. Crew et al., Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates - Reply, J UROL, 161(3), 1999, pp. 804-804
Risultati: 1-25 | 26-31 |